Q2 2025 |
72 |
$1.9B |
+$782M |
-$281M |
+$501M |
ACLX, JAZZ, CYTK, NUVL, VERA
|
13F-HR |
8/14/2025, 04:03 PM |
Q1 2025 |
63 |
$1.4B |
+$591M |
-$686M |
-$95.2M |
ACLX, CYTK, INSM, NUVL, VERA
|
13F-HR |
5/15/2025, 04:48 PM |
Q4 2024 |
73 |
$1.69B |
+$857M |
-$356M |
+$501M |
JAZZ, CYTK, MRK, ASND, RARE
|
13F-HR |
2/14/2025, 02:59 PM |
Q3 2024 |
67 |
$1.27B |
+$455M |
-$632M |
-$177M |
INSM, JAZZ, CYTK, NARI, ACLX
|
13F-HR |
11/14/2024, 02:00 PM |
Q2 2024 |
60 |
$1.34B |
+$595M |
-$357M |
+$238M |
JAZZ, CYTK, ASND, RARE, GMED
|
13F-HR |
8/14/2024, 02:10 PM |
Q1 2024 |
57 |
$1.21B |
+$664M |
-$428M |
+$237M |
CYTK, JAZZ, NBIX, ASND, GMED
|
13F-HR |
5/13/2024, 05:40 PM |
Q4 2023 |
48 |
$944M |
|
|
|
NBIX, JAZZ, ASND, INBX, SLNO
|
13F-HR |
2/13/2024, 03:42 PM |